Li, Junsheng და Kleeff, Jörg და Abiatari, Ivane და Kayed, Hany და Giese, Nathalia A და Felix, Klaus და Giese, Thomas და Büchler, Markus W და Friess, Helmut (2005) Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer. Molecular cancer, 4 (1). р. 14. ISSN 1476-4598
ტექსტი
1476-4598-4-14.pdf Download (889kB) |
რეზიუმე
UNLABELLED Hsulf-1 is a newly identified enzyme, which has the ability to decrease the growth of hepatocellular, ovarian, and head and neck squamous cell carcinoma cells by interfering with heparin-binding growth factor signaling. Since pancreatic cancers over-express a number of heparin-binding growth factors and their receptors, the expression and function of this enzyme in pancreatic cancer was analyzed. RESULTS Pancreatic cancer samples expressed significantly (22.5-fold) increased Hsulf-1 mRNA levels compared to normal controls, and Hsulf-1 mRNA was localized in the cancer cells themselves as well as in peritumoral fibroblasts. 4 out of 8 examined pancreatic cancer cell lines expressed Hsulf-1, whereas its expression was below the level of detection in the other cell lines. Stable transfection of the Hsulf-1 negative Panc-1 pancreatic cancer cell line with a full length Hsulf-1 expression vector resulted in increased sulfatase activity and decreased cell-surface heparan-sulfate proteoglycan (HSPG) sulfation. Hsulf-1 expression reduced both anchorage-dependent and -independent cell growth and decreased FGF-2 mediated cell growth and invasion in this cell line. CONCLUSION High expression of Hsulf-1 occurs in the stromal elements as well as in the tumor cells in pancreatic cancer and interferes with heparin-binding growth factor signaling.
ობიექტის ტიპი: | სტატია |
---|---|
თემატიკა: | R Medicine > R Medicine (General) |
განმათავსებელი მომხმარებელი: | Dr Ivane Abiatari |
განთავსების თარიღი: | 30 აპრილი 2015 05:29 |
ბოლო ცვლილება: | 30 აპრილი 2015 05:29 |
URI: | http://eprints.iliauni.edu.ge/id/eprint/2209 |
Actions (login required)
ობიექტის ნახვა |